$MGPI

MGP Ingredients earnings beat by $0.07, revenue fell short of estimates

MGP Ingredients (MGPI) reported Q3 EPS of $0.39, beating estimates by $0.07, but revenue of $117.9M missed expectations. The company forecasted FY 2026 EPS of $1.50-$1.80 and revenue of $480M-$500M, both below analyst consensus. The stock is down 13.45% in the last 3 months and 37.95% year-over-year.

Original reporting
Published Oct 28, 2026, 11:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MGPI
Neutral
medium confidence
Mentioned
$MGPI
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MGPINeutralMed
01

Why it matters

EPS beat with revenue miss often leads to a reassessment of demand and pricing assumptions, while the FY26 guidance ranges versus consensus frame expectations for the next several quarters.

02

Market read

MGPI’s quarter and FY26 guidance are the direct catalysts for near-term trading, especially given the stock’s recent underperformance and negative EPS revision trend.

03

What to watch

Traders may focus more on the direction of EPS revisions (0 positive, 5 negative in 90 days) and the stock’s large 12-month drawdown when interpreting the guidance.

Relevance 8/10Novelty 7/10Timing: post-earnings, same-day digestion of Q3 results and FY26 guidance

Background

The piece summarizes MGPI’s Q3 earnings versus consensus and provides FY26 EPS and revenue guidance ranges.

Company-level read

Ticker impact

$MGPINeutralMedium confidence
Context

MGPI reported Q3 EPS of $0.39, beating estimates by $0.07, but revenue missed at $117.9M vs $119.7M, alongside FY26 EPS and revenue guidance.

Expected impact

Likely choppy trading as the market digests EPS beat versus revenue miss and compares FY26 guidance ranges to consensus.

Evidence & confidence

The article provides both the beat/miss and explicit FY26 EPS and revenue guidance versus consensus, which typically drives near-term repricing and positioning.

Market effects

Limited spillover; this is a single-company results and guidance update rather than a sector-wide signal.

No clear regional transmission beyond US small/mid-cap consumer/food ingredients sentiment.

Low; no international policy, supply shock, or cross-border deal is described.

Counterpoint

The EPS beat could indicate margin or cost discipline that may offset revenue softness, making the guidance range less bearish than it first appears.

Key entities

  • MGP Ingredients

    NASDAQ-listed ingredients company reporting Q3 results and FY26 guidance.

Related articles

$MGPIMed

MGP Ingredients Reports Q3 Sales of $117.9 Million, Reaffirms 2026 Outlook

MGP Ingredients reported Q3 2026 sales of $117.9M, down 10% YoY, with net income of $6.9M. Adjusted EPS was $0.39, down from $0.85. The company reaffirmed its 2026 outlook and announced a name change to Sempreon on November 2. Sales growth was seen in Penelope Bourbon and mid-priced brands, while Distilling Solutions faced market challenges. Ingredient Solutions saw growth in specialty wheat proteins.

$MGPIMed

MGP Ingredients Reports Third Quarter 2026 Results

MGP INGREDIENTS INC (MGPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. MGP Ingredients Reports Third Quarter 2026 Results Company reaffirms full-year 2026 guidance, declares $0.12 quarterly dividend and will become Sempreon, Inc. (Nasdaq: CASK) on November 2 ATCHISON, Kan., October 28, 2026 - MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider

$MGPIMedAI 8/10

A bourbon brand's sales rose 12% as MGP Ingredients' total sales fell 10%.

MGP Ingredients reported a 10% decline in total sales for Q3 2026, with Branded Spirits sales down 4% and Distilling Solutions sales down 29%. Penelope Bourbon sales rose 12%. Gross profit fell 18% to $40.5M. The company reaffirmed its 2026 guidance, expecting sales of $480M-$500M and adjusted EBITDA of $82M-$90M. MGP will change its name to Sempreon, Inc. and ticker to CASK on November 2, 2026.

$TSNHigh

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills Shares Are Falling, What You Need To Know

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills shares fell due to U.S. cattle shortages and margin pressures. Tyson cut its 2026 adjusted operating income outlook to $2.1B-$2.3B, citing beef-segment losses. The company is closing plants and exploring sales to restructure. Other firms also saw declines. Tyson's stock is down 11% YTD and 24.8% from its 52-week high.